HIF-1α expression in the hippocampus and peripheral macrophages after glutamate-induced excitotoxicity

Journal of Neuroimmunology

Volumn 238, Issue 1-2, 2011, Pages 12-18

  Vazquez Valls, E ^a   Flores Soto, M E ^b   Chaparro Huerta, V ^b   Torres Mendoza, B M ^b,c   Gudino Cabrera G ^d   Rivera Cervantes, M C ^e   Pallas, M ^f   Camins, A ^f   Armendariz Borunda J ^g   Beas Zarate, C ^b,d  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

^c Instituto de Neurociencias   (Mexico)

^d Departamento de Biología Celular y Molecular   (Mexico)

^e CUCBA U DE G   (Mexico)

^f UNIVERSITY OF BARCELONA   (Spain)

^g UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

EPO; Excitotoxicity; HIF 1 alpha; Hippocampus; Macrophages; VEGF

Indexed keywords

ERYTHROPOIETIN; GLUTAMIC ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXCITOTOXICITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GLIA CELL; HIPPOCAMPUS; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; HIPPOCAMPUS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACROPHAGES; MALE; NEURONS; NEUROTOXICITY SYNDROMES; NEUROTOXINS; PREGNANCY; RATS; RATS, WISTAR; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80052829111     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.06.001     Document Type: Article

References (47)

1. Beas Zárate C., Rivera-Huizar S.V., Martinez-Contreras A., Feria-Velasco A., Armendariz-Borunda J. Changes in NMDA-receptor gene expression are associated with neurotoxicity induced neonatally by glutamate in the rat brain. Neurochem. Int. 2001, 39:1-10.
2. Beas-Zárate C., Ureña-Guerrero M.E., Flores-Soto M., Armendariz-Borunda J., Ortuño-Sahagún D. The expression and binding of kainate receptors is modified in different brain regions by glutamate neurotoxicity during postnatal rat development. Int. J. Dev. Neurosci. 2007, 25(1):53-61.
3. Bogaert E., Van Damme P., Poesen K., Dhondt J., Hersmus N., Kiraly D., Scheveneels W., Robberecht W., Van Den Bosch L. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiol. Aging 2010, 31(12):2185-2191.
4. Brune B., Zhou J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc. Res. 2007, 75:275-282.
5. Castellani R.J., Lee H.G., Zhu X., Perry G., Smith M.A. Alzheimer disease pathology as a host response. J. Neuropathol. Exp. Neurol. 2008, 67(6):523-531. Review.
6. Chaparro-Huerta V., Rivera-Cervantes M.C., Torres-Mendoza B.M., Beas-Zarate C. Neuronal death and tumor necrosis factor-alpha response to glutamate-induced excitotoxicity in the cerebral cortex of neonatal rats. Neurosci. Lett. 2002, 333(2):95-98.
7. Chaparro-Huerta V., Rivera-Cervantes M.C., Flores-Soto M.E., Gomez-Pinedo U., Beas-Zarate C. Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats. J. Neuroimmunol. 2005, 165(1-2):53-62.
8. Chaparro-Huerta V., Flores-Soto M.E., Gudiño-Cabrera G., Rivera-Cervantes M.C., Bitzer-Quintero O.K., Beas-Zárate C. Role of p38 MAPK and pro-inflammatory cytokines expression in glutamate-induced neuronal death of neonatal rats. Int. J. Dev. Neurosci. 2008, 26(5):487-495.
9. Chen G., Shi J.X., Hang C.H., Xie W., Liu J., Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci. Lett. 2007, 425(3):177-182.
10. Chomczynski P., Sacchi N. Single-step of isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
11. De Ponti C., Carini R., Alchera E., Nitti M.P., Locati M., Albano E., Cairo G., Tacchini L. Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages. J. Leukoc. Biol. 2007, 82(2):392-402.
12. Dehne N., Brune B. HIF-1 in the inflammatory microenvironment. Expl. Cell Res. 2009, 315:1791-1797.
13. Drew K.L., Rice M.E., Kuhn T.B., Smith M.A. Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases. Free Radic. Biol. Med. 2001, 31(5):563-573. Sep 1.
14. Ernens I., Léonard F., Vausort M., Rolland-Turner M., Devaux Y., Wagner D.R. Adenosine up-regulates vascular endothelial growth factor in human macrophages. Biochem. Biophys. Res. Commun. 2010, 392(3):351-356.
15. Fujiki M., Abe E., Nagai Y., Shiqi K., Kubo T., Ishii K., Abe T., Kobayashi H. Electroconvulsive seizure-induced VEGF is correlated with neuroprotective effects against cerebral infarction: involvement of the phosphatidylinositol-3 kinase/Akt pathway. Exp. Neurol. 2010, 225(2):377-383.
16. Gensel J.C., Nakamura S., Guan Z., van Rooijen N., Ankeny D.P., Popovich P.G. Macrophages promote axon regeneration with concurrent neurotoxicity. J. Neurosci. 2009, 29(12):3956-3968.
17. Gras G., Porcheray F., Samah B., Leone C. The glutamate-glutamine cycle as an inducible, protective face of macrophage activation. J. Leukoc. Biol. 2006, 80(5):1067-1075.
18. Huang L.E., Bunn H.F. Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem. 2003, 278:19575-19578.
19. Khan H.A. Time-course evaluation of whole blood phagocytosis in mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Inflammopharmacol. 2004, 12(1):81-88.
20. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29(43):13435-13444.
21. Kilic U., Kilic E., Järve A., Guo Z., Spudich A., Bieber K., Barzena U., Bassetti C.L., Marti H.H., Hermann D.M. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J. Neurosci. 2006, 26(48):12439-12446. 29.
22. Lemus-Varela M.L., Flores-Soto M.E., Cervantes-Munguía R., Torres-Mendoza B.M., Gudiño-Cabrera G., Chaparro-Huerta V., Ortuño-Sahagún D., Beas-Zárate C. Expression of HIF-1 alpha, VEGF and EPO in peripheral blood from patients with two cardiac abnormalities associated with hypoxia. Clin. Biochem. 2010, 43(3):234-239.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193(1):265-275.
24. Lunn J.S., Sakowski S.A., Kim B., Rosenberg A.A., Feldman E.L. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. Dev. Neurobiol. 2009, 69(13):871-884.
25. Manoonkitiwongsa P.S. Critical questions for preclinical trials on safety and efficacy of vascular endothelial growth factor-based therapeutic angiogenesis for ischemic stroke. CNS Neurol. Disord. Drug Targets 2011, 10(2):215-234.
26. Martinez-Contreras A., Huerta M., Lopez-Perez S., Garcia-Estrada J., Luquin S., Beas Zarate C. Astrocytic and microglia cells reactivity induced by neonatal administration of glutamate in cerebral cortex of the adult rats. J. Neurosci. Res. 2002, 67(2):200-210.
27. Minet E., Michel G., Mottet D., Raes M., Michiels C. Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radic. Biol. Med. 2001, 31:847-855.
28. Moxon-Emre I., Schlichter L.C. Evolution of inflammation and white matter injury in a model of transient focal ischemia. J. Neuropathol. Exp. Neurol. 2010, 69(1):1-15.
29. Nicoletti J.N., Lenzer J., Salerni E.A., Shah S.K., Elkady A., Khalid S., Quinteros D., Rotella F., Betancourth D., Croll S.D. Vascular endothelial growth factor attenuates status epilepticus-induced behavioral impairments in rats. Epilepsy Behav. 2010, 19(3):272-277.
30. Pacheco R., Gallart T., Lluis C., Franco R. Role of glutamate on T-cell mediated immunity. J. Neuroimmunol. 2007, 185(1-2):9-19.
31. Porcheray F., Léone C., Samah B., Rimaniol A.C., Dereuddre-Bosquet N., Gras G. Glutamate metabolism in HIV-infected macrophages: implications for the CNS. Am. J. Physiol. Cell Physiol. 2006, 291(4):C618-C626.
32. Rosenstein J.M., Krum J.M., Ruhrberg C. VEGF in the nervous system. Organogenesis. 2010, 6(2):107-114.
33. Sayre L.M., Perry G., Smith M.A. Oxidative stress and neurotoxicity. Chem. Res. Toxicol. 2008, 21(1):172-188. Jan.
34. Semenza G.L. O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J. Appl. Physiol. 2004, 96:1173-1177.
35. Seta K.A., Millhorn D.E. Functional genomics approach to hypoxia signaling. J. Appl. Physiol. 2004, 96:765-773.
36. Thomas D.D., Ridnour L.A., Isenberg J.S., Flores-Santana W., Switzer C.H., Donzelli S., Hussain P., Vecoli C., Paolocci N., Ambs S., Colton C.A., Harris C.C., Roberts D.D., Wink D.A. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic. Biol. Med. 2008, 45(1):18-31. Jul 1.
37. Tian Y.Y., Sun S.G., Wang J.N., Tang C.J., Feng Y., Wang L., Chen X.W., Qiao X. Adenovirus mediated vascular endothelial growth factor gene transfer protects dopaminergic neurons in Parkinson's disease: experiment with rats. Zhonghua Yi Xue Za Zhi 2006, 86(29):2054-2059.
38. Tolosa L., Mir M., Asensio V.J., Olmos G., Lladó J. Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J. Neurochem. 2008, 105(4):1080-1090.
39. Toyooka K., Fujimura H. Iatrogenic neuropathies. Curr. Opin. Neurol. 2009, 22(5):475-479.
40. Vezzani A. VEGF as a target for neuroprotection. Epilepsy Curr. 2008, 8(5):135-137. Sep-Oct.
41. Wang Y.Q., Sun F.Y. Neuroprotective mechanisms of vascular endothelial growth factor. Sheng Li Ke Xue Jin Zhan 2007, 38(3):202-207.
42. Weidemann A., Kerdiles Y.M., Knaup K.X., Rafie C.A., Boutin A.T., Stockmann C., Takeda N., Scadeng M., Shih A.Y., Haase V.H., Simon M.C., Kleinfeld D., Johnson R.S. The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. J. Clin. Invest. 2009, 119(11):3373-3383.
43. Xiong N., Zhang Z., Huang J., Chen C., Zhang Z., Jia M., Xiong J., Liu X., Wang F., Cao X., Liang Z., Sun S., Lin Z., Wang T. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Ther. 2011, 18(4):394-402.
44. Xu J., Kurup P., Zhang Y., Goebel-Goody S.M., Wu P.H., Hawasli A.H., Baum M.L., Bibb J.A., Lombroso P.J. Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J. Neurosci. 2009, 29(29):9330-9343.
45. Zhang B., Tanaka J., Yang L., Yang L., Sakanaka M., Hata R., Maeda N., Mitsuda N. Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor 1. Neurosci. 2004, 126:433-440.
46. Zhao H., Bao X.J., Wang R.Z., Li G.L., Gao J., Ma S.H., Wei J.J., Feng M., Zhao Y.J., Ma W.B., Yang Y., Li Y.N., Kong Y.G. Postacute ischemia vascular endothelial growth factor transfer by transferrin-targeted liposomes attenuates ischemic brain injury after experimental stroke in rats. Hum. Gene Ther. 2011, 22(2):207-215.
47. Zipp F., Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 2006, 29(9):518-527.